Lumira Ventures
Gerry Brunk is a seasoned professional in the healthcare venture capital sector, currently serving as Managing Director at Lumira Ventures since June 2002, where the focus is on funding and supporting life science innovations. Brunk holds board positions at several medical technology and biotechnology companies, including Sound Blade Medical Inc., SpectraWAVE, Inc., Endogenex, HistoSonics, Inc., Cadence Neuroscience Inc., Engene Inc., PIC Therapeutics, GenEp, and Cyrano Therapeutics. Educational credentials include an MBA from Stanford University Graduate School of Business and a BA in Biology and Economics from the University of Virginia.
This person is not in any teams
This person is not in any offices
Lumira Ventures
Lumira Ventures is a leading healthcare and life sciences venture capital firm, investing in innovative entrepreneurs developing best and first-in-class therapeutics & medical technologies across North America. We are engaged partners who support the management teams of companies we invest in to build products that have the potential to allow people to lead fundamentally healthier, longer, and more productive lives.